Qrons Inc. financial data

Symbol
QRON on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
28 10 Jackson Avenue, #26 N, Long Island City, NY
State of incorporation
WY
Fiscal year end
December 31
Former names
BIOLABMART INC. (to 7/18/2017)
Latest financial report
10-K - Q4 2024 - Apr 16, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.45 % +29%
Debt-to-equity -100 % -0.08%
Return On Equity 5.09 % -91%
Return On Assets -1.24K % +92.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.9M shares +31.2%
Common Stock, Shares, Outstanding 17.6M shares +28.9%
Entity Public Float 881K USD -33.6%
Common Stock, Value, Issued 1.76K USD +28.9%
Weighted Average Number of Shares Outstanding, Diluted 13.9M shares +2.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Research and Development Expense 222K USD -51.9%
General and Administrative Expense 53K USD -52%
Operating Income (Loss) -344K USD +46.5%
Net Income (Loss) Attributable to Parent -56.1K USD +92.9%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.64K USD -19%
Assets, Current 659 USD +56.9%
Assets 659 USD +56.9%
Liabilities, Current 432K USD -67.3%
Liabilities 446K USD -70.1%
Retained Earnings (Accumulated Deficit) -10.4M USD -0.54%
Stockholders' Equity Attributable to Parent -445K USD +70.1%
Liabilities and Equity 659 USD +56.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.3K USD -42%
Net Cash Provided by (Used in) Financing Activities 22.5K USD +50%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 17.6M shares +28.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 659 USD +56.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Preferred Stock, Shares Issued 2K shares 0%
Preferred Stock, Shares Authorized 10K shares 0%
Additional Paid in Capital 9.93M USD +12.4%
Preferred Stock, Shares Outstanding 2K shares 0%
Interest Expense 59.4K USD -43.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%